| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.8M | -74.6% |
| R&D Expense | $50.2M | +15.5% |
| SG&A Expense | $36.7M | +1969.3% |
| Operating Income | -$112.6M | -6243.2% |
| Pre-tax Income | -$585.5M | -743.0% |
| Income Tax | $3K | +200.0% |
| Net Income | -$585.5M | -2353.2% |
| EPS (Basic) | -$6.42 | -439.5% |
| EPS (Diluted) | -$6.42 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.8M | +5104.6% |
| Accounts Receivable | $879K | -31.3% |
| Current Assets | $126.0M | — |
| Total Assets | $159.4M | -71.1% |
| Current Liabilities | $26.7M | +3500.2% |
| Long-term Debt | $29.9M | +497.6% |
| Total Liabilities | $219.3M | +843.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.4M | — |
| Capital Expenditures | $22.0M | +590.0% |
| Investing Cash Flow | -$91.4M | — |
| Financing Cash Flow | $219.9M | — |
| Free Cash Flow | -$116.5M | -2725.7% |
| -439.5% |
| Stockholders' Equity |
| -$283.1M |
| -1184.3% |